首页> 美国卫生研究院文献>PLoS Pathogens >Relatively Low Level of Antigen-specific Monocytes Detected in Blood from Untreated Tuberculosis Patients Using CD4+ T-cell Receptor Tetramers
【2h】

Relatively Low Level of Antigen-specific Monocytes Detected in Blood from Untreated Tuberculosis Patients Using CD4+ T-cell Receptor Tetramers

机译:使用CD4 + T细胞受体四聚体从未经治疗的结核病患者血液中检测到的抗原特异性单核细胞水平相对较低

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The in vivo kinetics of antigen-presenting cells (APCs) in patients with advanced and convalescent tuberculosis (TB) is not well characterized. In order to target Mycobacterium tuberculosis (MTB) peptides- and HLA-DR-holding monocytes and macrophages, 2 MTB peptide-specific CD4+ T-cell receptor (TCR) tetramers eu and hu were successfully constructed. Peripheral blood (PBL) samples from inpatients with advanced pulmonary TB (PTB) were analyzed using flow cytometry, and the percentages of tetramer-bound CD14+ monocytes ranged from 0.26–1.44% and 0.21–0.95%, respectively; significantly higher than those measured in PBL samples obtained from non-TB patients, healthy donors, and umbilical cords. These tetramers were also able to specifically detect macrophages in situ via immunofluorescent staining. The results of the continuous time-point tracking of the tetramer-positive rates in PBL samples from active PTB outpatients undergoing treatment show that the median percentages were at first low before treatment, increased to their highest levels during the first month, and then began to decrease during the second month until finally reaching and maintaining a relatively low level after 3–6 months. These results suggest that there is a relatively low level of MTB-specific monocytes in advanced and untreated patients. Further experiments show that MTB induces apoptosis in CD14+ cells, and the percentage of apoptotic monocytes dramatically decreases after treatment. Therefore, the relatively low level of MTB-specific monocytes is probably related to the apoptosis or necrosis of APCs due to live bacteria and their growth. The bactericidal effects of anti-TB drugs, as well as other unknown factors, would induce a peak value during the first month of treatment, and a relatively low level would be subsequently reached and maintained until all of the involved factors reached equilibrium. These tetramers have diagnostic potential and can provide valuable insights into the mechanisms of antigen presentation and its relationship with TB infection and latent TB infection.
机译:晚期和康复期结核病(TB)患者中的抗原呈递细胞(APC)的体内动力学尚未很好地表征。为了靶向结核分枝杆菌(MTB)肽和持有HLA-DR的单核细胞和巨噬细胞,成功构建了2种MTB肽特异性CD4 + T细胞受体(TCR)四聚体eu和hu。使用流式细胞仪分析了晚期肺结核(PTB)住院患者的外周血(PBL)样本,四聚体结合的CD14 + 单核细胞的百分比范围为0.26-1.44%和0.21-0.95%,分别;显着高于从非结核病患者,健康捐献者和脐带中获得的PBL样品中的含量。这些四聚体还能够通过免疫荧光染色原位特异性检测巨噬细胞。连续时间点跟踪来自接受治疗的活跃PTB门诊患者的PBL样本中四聚体阳性率的结果表明,中位百分比最初在治疗前较低,在第一个月内增加到最高水平,然后开始下降。在第二个月下降,直到3-6个月后最终达到并保持相对较低的水平。这些结果表明,在晚期和未经治疗的患者中,MTB特异性单核细胞的水平相对较低。进一步的实验表明,MTB诱导CD14 + 细胞凋亡,治疗后凋亡单核细胞百分比明显降低。因此,相对较低的MTB特异性单核细胞水平可能与由于活细菌及其生长引起的APC的凋亡或坏死有关。抗结核药物以及其他未知因素的杀菌作用会在治疗的第一个月内达到峰值,随后将达到并维持相对较低的水平,直到所有相关因素达到平衡。这些四聚体具有诊断潜力,可以为抗原呈递机制及其与TB感染和潜在TB感染的关系提供有价值的见解。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号